Recorded Chinese product: 聚乙烯醇滴眼液聚乙烯醇滴眼液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司
主要成分Active Ingredients
- 聚乙烯醇Juyi Xichun
药物知识说明
聚乙烯醇是一种在国家药监局注册认定的药品。该药品含有聚乙烯醇-86bd41be等成分。
该药品关联的活性成分包括：聚乙烯醇Juyi Xichun。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司。
您可以探索含有相同成分的其他药品：聚乙烯醇-86bd41be成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 聚乙烯醇滴眼液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 聚乙烯醇Juyi Xichun.
Manufacturers recorded for this product: 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司.
Explore other medicines containing the same ingredient: 聚乙烯醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 聚乙烯醇滴眼液Recorded Chinese product: 聚乙烯醇滴眼液
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 0.8ml*10支0.8 mL × 10 units
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20046681
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20046681
Manufacturer
Chinese legal name: 湖北远大天天明制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
0.8 mL × 10 units
中文说明书原文Original Chinese source label
批准文号
国药准字H20046681
生产企业
湖北远大天天明制药有限公司(国产)
适应症
可作为一种润滑剂预防或治疗眼部干涩、异物感、眼疲劳等刺激症状或改善眼部的干燥症状。
用法用量
每次一滴，滴于患眼。
不良反应
偶有眼部刺激症状和过敏反应。
禁忌
对本品过敏者禁用。
注意事项
1.勿让滴嘴接触任何物体表面以避免污染，用后请盖好瓶盖。|2.滴眼后若觉眼痛、视力模糊、眼部持续充血或刺激症状或病情加重，且持续时间超过72小时，应停止使用或向医生咨询。|3.若药液变色或浑浊，勿再使用。|4.配戴软性隐形眼镜时请将隐形眼镜摘下后滴用本品。|5.对本品过敏者禁用，过敏体质者慎用。|6.本品性状发生改变时禁止使用。|7.请将本品放在儿童不能接触的地方。|8.儿童必须在成人监护下使用。|9.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密闭保存。
规格
0.8ml*10支
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.